• 1. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525
• 2. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 3. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 4. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 5. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244

Professional Introduction to N-5-(Aminomethyl)-2-pyridinyl-N-benzyl-N-ethylamine (CAS No. 1152523-44-8)

N-5-(Aminomethyl)-2-pyridinyl-N-benzyl-N-ethylamine, identified by its CAS number 1152523-44-8, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology. This compound belongs to the class of pyridine derivatives, which are widely recognized for their diverse biological activities and potential therapeutic applications. The structural features of this molecule, particularly the presence of an aminomethyl group, a benzyl moiety, and an ethylamine side chain, contribute to its unique chemical properties and biological interactions.

The N-5-(aminomethyl)-2-pyridinyl-N-benzyl-N-ethylamine molecule exhibits a high degree of complexity, which makes it a promising candidate for further research in drug discovery and development. The pyridine core is a key pharmacophore in many bioactive molecules, and its structural versatility allows for the design of compounds with tailored biological functions. The introduction of the aminomethyl group at the 5-position of the pyridine ring enhances the compound's ability to interact with biological targets, while the benzyl and ethylamine substituents contribute to its solubility and stability in various chemical environments.

In recent years, there has been a growing interest in developing novel therapeutic agents that target specific biological pathways associated with human diseases. The N-5-(aminomethyl)-2-pyridinyl-N-benzyl-N-ethylamine compound has been studied for its potential role in modulating various cellular processes. For instance, preliminary studies suggest that this molecule may interfere with signal transduction pathways involved in cancer cell proliferation and survival. The ability of the aminomethyl, benzyl, and ethylamine groups to engage with proteins and enzymes has opened up new avenues for drug design, particularly in the development of small-molecule inhibitors.

The synthesis of CAS No. 1152523-44-8 involves multi-step organic reactions that require precise control over reaction conditions to ensure high yield and purity. Advanced synthetic techniques, such as palladium-catalyzed cross-coupling reactions and nucleophilic substitutions, have been employed to construct the desired molecular framework. These synthetic strategies not only highlight the synthetic prowess of modern organic chemistry but also underscore the importance of innovative methodologies in producing complex molecules like this one.

The pharmacological profile of N-5-(Aminomethyl)-2-pyridinyl-N-Benzyl-N-Ethylamine has been investigated in several preclinical studies. These studies have revealed that the compound exhibits significant binding affinity for certain protein targets, suggesting its potential as a lead compound for further development. The interaction between this molecule and its biological targets is mediated by its structural features, particularly the hydrogen bonding capabilities of the Aminomethyl, π-stacking interactions involving the pyridine ring, and hydrophobic interactions with aromatic residues in protein binding pockets.

In addition to its therapeutic potential, N-5-(Aminomethyl)-2-pyridinyl-N-Benzyl-N-Ethylamine has also been explored for its role in chemical biology research. Its unique structural composition makes it an excellent tool for studying enzyme mechanisms and protein-protein interactions. By using this compound as a probe molecule, researchers can gain insights into how small molecules modulate complex biological systems. This approach has been particularly valuable in understanding disease pathogenesis and identifying new therapeutic targets.

The development of novel pharmaceutical agents often requires interdisciplinary collaboration between chemists, biologists, and pharmacologists. The case of N-5-(Aminomethyl)-2-pyridinyl-N-Benzyl-N-Ethylamine exemplifies this collaborative effort. Chemists have synthesized and optimized this compound based on structural considerations, while biologists have conducted experiments to evaluate its biological activity. Pharmacologists have then translated these findings into potential clinical applications. This integrated approach is essential for translating basic research into tangible therapeutic benefits for patients.

The future prospects for N-5-(Aminomethyl)-2-pyridinyl-N-Benzyl-N-Ethylamine are promising, given its unique structural features and potential therapeutic applications. Further research is needed to fully elucidate its mechanism of action and assess its safety profile in preclinical models. As our understanding of disease biology continues to evolve, compounds like this one will play an increasingly important role in developing targeted therapies that address unmet medical needs.

In conclusion, N-5-(Aminomethyl)-2-pyridinyl-N-Benzyl-N-Ethylamine (CAS No. 1152523-44-8) is a structurally complex organic compound with significant potential in pharmaceutical research and drug development. Its unique combination of functional groups makes it an attractive candidate for modulating various biological pathways associated with human diseases. As ongoing research continues to uncover new insights into its pharmacological properties, this compound is poised to make meaningful contributions to both academic research and clinical medicine.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)